Nu Skin Enterprises (NUS, Financial) experienced a significant stock price drop, decreasing by 5.12%. The stock is currently valued at $6.12 per share with a trading volume of 298,721 shares and a turnover rate of 0.60%. The stock's fluctuation amplitude is 3.80%. Recent financial results show revenue of $439 million and a net loss of $118 million, resulting in an earnings per share of -$2.38 and a gross profit of $307 million. The price-to-earnings ratio stands at -2.06. Currently, there are no institutional ratings of "buy," "hold," or "sell" for the stock.
Within the personal products industry, where Nu Skin operates, the overall growth is 1.26%. In related stocks, Helen of Troy, Carmell Corporation, and Big Tree Cloud Holdings are performing strongly, with Carmell Corporation showing high activity with a turnover rate of 177.13%. Notably, Big Tree Cloud Holdings exhibited a fluctuation amplitude of 32.44%, with Carmell Corporation and Big Tree Cloud Holdings also showing significant volatility.
Nu Skin Enterprises is a direct-selling company specializing in health and beauty products, with two primary categories: beauty and wellness. It operates over 50 countries across the Americas, Europe, and the Asia-Pacific region under brands such as Nu Skin and Pharmanex, offering nutrition, weight management, and dietary supplements.
